February 16, 2026 a 08:00 am

COO: Fundamental Ratio Analysis - The Cooper Companies, Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc. presents a balanced investment opportunity in the healthcare sector. With its dual focus on CooperVision and CooperSurgical, it leverages a diverse product portfolio in vision care and women's health. Although the company faces competition and regulatory challenges, its established market presence and innovation in product development are noteworthy.

Fundamental Rating

The fundamental analysis reflects a moderate performance with room for improvement across various financial metrics.

Category Score Visual
Discounted Cash Flow 3
Return on Equity 3
Return on Assets 3
Debt to Equity 2
Price to Earnings 2
Price to Book 3

Historical Rating

The historical scores provide insight into the company's financial progression and areas in need of focus.

Date Overall Score DCF ROE ROA Debt/Equity P/E P/B
2026-02-13 3 3 3 3 2 2 3
Previous 0 3 3 3 2 2 3

Analyst Price Targets

Analysts provide mixed projections, suggesting caution around market volatility and potential upside within set ranges.

High Low Median Consensus
$100 $73 $96.5 $91.63
COO Stock Chart

Analyst Sentiment

The sentiment leans positive, with a majority of analysts recommending a buy.

Recommendation Count Visual
Strong Buy 0
Buy 15
Hold 8
Sell 1
Strong Sell 0

Conclusion

The Cooper Companies, Inc. offers a stable investment opportunity within the healthcare sector with a focus on vision care and women's health. While the company demonstrates moderate financial performance, its ratings suggest potential for improvement. Analyst sentiment remains positive, although investors should consider the potential risks associated with competition and market changes. The stock offers growth potential but requires a balanced approach to portfolio allocation.